MedPath

HUMANITAS MIRASOLE SPA

🇮🇹Italy
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.humanitas.net

High Blood Eosinophils and FeNO Levels Predict Better Dupilumab Response in Moderate-to-Severe Asthma

Post-hoc analysis of LIBERTY ASTHMA QUEST trial reveals patients with elevated blood eosinophils and FeNO levels show significantly higher odds of achieving clinical remission with dupilumab treatment.

© Copyright 2025. All Rights Reserved by MedPath